{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:17:24Z","timestamp":1788956244712,"version":"build-2803163510"},"reference-count":36,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Einstein (S\u00e3o Paulo)"],"abstract":"<jats:p>ABSTRACT  Objective  To investigate antifungal susceptibility and factors associated with oral colonization by Candida species in HIV-positive patients.  Methods  A prospective study based on convenience sampling of subjects recruited from a pool of confirmed HIV-positive individuals seen at a specialty outpatient service in Rondon\u00f3polis, Mato Grosso, Brazil). Oral swabs were collected from 197 patients. Candida species were identified by standard microbiological techniques (phenotypic and molecular methods). Antifungal susceptibility was investigated using the broth microdilution method.  Results  A total of 101 (51.3%) patients were Candida spp carriers. Candida albicans was the most prevalent species (80%). Patients aged 45 to 59 years (Prevalence ratios: 1.90; 95%CI: 1.57-6.31) and 60 years or older (Prevalence ratios: 4.43; 95%CI: 1.57-34.18) were at higher risk of oral colonization by Candida species. Resistance to fluconazole and ketoconazole, or to itraconazole, corresponded to 1% and 4%, respectively.  Conclusion  Age (45 years or older) was the only factor associated with oral colonization by Candida . Low rates of antifungal resistance to azoles were detected in yeast isolates obtained from HIV-positive patients. Findings of this study may contribute to proper therapeutic selection for oral candidiasis in HIV-positive patients.<\/jats:p>","DOI":"10.1590\/s1679-45082018ao4224","type":"journal-article","created":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T15:34:43Z","timestamp":1533396883000},"source":"Crossref","is-referenced-by-count":32,"title":["Oral colonization by Candida species in HIV-positive patients: association and antifungal susceptibility study"],"prefix":"10.1590","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1452-4908","authenticated-orcid":false,"given":"Let\u00edcia Silveira","family":"Goulart","sequence":"first","affiliation":[{"name":"Universidade Federal de Mato Grosso,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6778-3837","authenticated-orcid":false,"given":"Werika Weryanne Rosa de","family":"Souza","sequence":"additional","affiliation":[{"name":"Universidade Federal de Mato Grosso,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9333-7619","authenticated-orcid":false,"given":"Camila Aoyama","family":"Vieira","sequence":"additional","affiliation":[{"name":"Universidade Federal de Mato Grosso,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3942-4583","authenticated-orcid":false,"given":"Janaina Sousa de","family":"Lima","sequence":"additional","affiliation":[{"name":"Universidade Federal de Mato Grosso,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0509-8428","authenticated-orcid":false,"given":"Ricardo Alves de","family":"Olinda","sequence":"additional","affiliation":[{"name":"Universidade Estadual da Para\u00edba,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3043-2731","authenticated-orcid":false,"given":"Claudin\u00e9ia de","family":"Ara\u00fajo","sequence":"additional","affiliation":[{"name":"Universidade Federal de Mato Grosso,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"ref1","series-title":"Boletim Epidemiol\u00f3gico: HIV, AIDS. Ano v, n\u00ba 01. 27\u00aa a 53\u00aa semanas epidemiol\u00f3gicas - julho a dezembro de 2015, 01\u00aa a 26\u00aa - semanas epidemiol\u00f3gicas - janeiro a junho de 2016","year":"2016"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cden.2016.12.006","article-title":"Recent Recommendations for Management of Human Immunodeficiency Virus-Positive Patients","volume":"61","author":"Robbins MR","year":"2017","journal-title":"Dent Clin North Am"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.archoralbio.2013.05.002","article-title":"Periodontal disease in HIV-infected adults in the HAART era: Clinical, immunological, and microbiological aspects","volume":"58","author":"Gon\u00e7alves LS","year":"2013","journal-title":"Arch Oral Biol"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/0022034511399284","article-title":"Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis","volume":"23","author":"Fidel Jr PL","year":"2011","journal-title":"Adv Dent Res"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/apm.12006","article-title":"Oropharyngeal Candida colonization in human immunodeficiency virus infected patients","volume":"121","author":"Li X","year":"2013","journal-title":"APMIS"},{"issue":"1","key":"ref6","first-page":"22","article-title":"Candid\u00edase","volume":"22","author":"Barbedo LS","year":"2010","journal-title":"J Bras Doen\u00e7as Sex Transm"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.clindermatol.2009.12.014","article-title":"Candidosis, a new challenge","volume":"28","author":"L\u00f3pez-Mart\u00ednez R","year":"2010","journal-title":"Clin Dermatol"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1586\/14787210.2014.916210","article-title":"Pathogenicity mechanisms and host response during oral Candida albicans infections","volume":"12","author":"Hebecker B","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/myc.12330","article-title":"Antifungal drug resistance among Candida species: mechanisms and clinical impact","volume":"58","author":"Sanguinetti M","year":"2015","journal-title":"Mycoses"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1590\/S0036-46652015000700011","article-title":"Susceptibility test for fungi: clinical and laboratorial correlations in medical mycology","volume":"57","author":"Alastruey-Izquierdo A","year":"2015","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/JCM.00937-12","article-title":"Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012","volume":"50","author":"Pfaller MA","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"3","key":"ref12","first-page":"121","article-title":"Candida albicans identification: comparison among nine phenotypic systems and a multiplex PCR","volume":"51","author":"Liguori G","year":"2010","journal-title":"J Prev Med Hyg"},{"key":"ref13","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. CLSI document M27-A3","year":"2008","edition":"3rd"},{"key":"ref14","series-title":"Reference method for broth dilution antifungal susceptibility testing yeasts. CLSI document M27-S4","year":"2017"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-13-82","article-title":"Frequent detection of \u2018azole\u2019 resistant Candida species among late presenting AIDS patients in northwest Ethiopia","volume":"13","author":"Mulu A","year":"2013","journal-title":"BMC Infec Dis"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1590\/S0036-46652006000500004","article-title":"Asymptomatic oral carriage of Candida species in HIV-infected patients in the highly active antiretroviral therapy era","volume":"48","author":"Costa CR","year":"2006","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref17","article-title":"Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China","volume":"13","author":"Li YY","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3855\/jidc.6970","article-title":"Oral Candida colonization in HIV-infected patients in Londrina-PR, Brazil: antifungal susceptibility and virulence factors","volume":"9","author":"Paula SB","year":"2015","journal-title":"J Infect Dev Ctries"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jmii.2012.07.009","article-title":"Predisposing factors for oropharyngeal colonization of yeasts in human immunodeficiency virus-infected patients: a prospective cross-sectional study","volume":"46","author":"Lin JN","year":"2013","journal-title":"J Microbiol Immunol Infect"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.3402\/ljm.v8i0.20322","article-title":"Candida colonisation in asymptomatic HIV patients attending a tertiary hospital in Benin City, Nigeria","volume":"8","author":"Esebelahie NO","year":"2013","journal-title":"Libyan J Med"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3037817","article-title":"Spectrum and the In Vitro Antifungal Susceptibility Pattern of Yeast Isolates in Ethiopian HIV Patients with Oropharyngeal Candidiasis","volume":"2016","author":"Moges B","year":"2016","journal-title":"Inter J Microbiol"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.15547\/tjs.2016.01.008","article-title":"Oropharyngeal Candidiasis and antifungal assessment of Candida glabrata in patients with HIV infection","volume":"14","author":"Sharifzadeh A","year":"2016","journal-title":"Trakia J Sciences"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.17533\/udea.iatreia.v28n4a02","article-title":"Candida en la cavidad oral de pacientes con VIH en Cali, Colombia: determinaci\u00f3n de especies y sensibilidad al fluconazol","volume":"28","author":"Castro LA","year":"2015","journal-title":"Iatreia"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1099\/jmm.0.047522-0","article-title":"Oral Candida colonization in HIV positive women: associated factors and changes with antiretroviral therapy","volume":"62","author":"Owotade FJ","year":"2013","journal-title":"J Med Microbiol"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.oooo.2014.07.004","article-title":"Virulence of oral Candida isolated from HIV-positive women with oral candidiasis and asymptomatic carriers","volume":"118","author":"Owotade FJ","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1469-0691.2011.03655.x","article-title":"Oropharyngeal yeast colonization in HIV-infected outpatients in southern Taiwan: CD4 count, efavirenz therapy and intravenous drug use matter","volume":"18","author":"Wu CJ","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1590\/S0036-46652012000100004","article-title":"Oral colonization by yeasts in HIV-positive patients in Brazil","volume":"54","author":"Junqueira JC","year":"2012","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4103\/0973-029X.92971","article-title":"Isolation, identification, and carriage of candidal species in PHLAs and their correlation with immunological status in cases with and without HAART","volume":"16","author":"Kantheti LP","year":"2012","journal-title":"J Oral Maxillofac Pathol"},{"issue":"26","key":"ref29","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.2174\/092986707782360141","article-title":"Inhibitors of HIV-1 Protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors","volume":"14","author":"Mastrolorenzo A","year":"2007","journal-title":"Curr Med Chem"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4331\/wjbc.v1.i2.21","article-title":"HIV aspartyl protease inhibitors as promising compounds against Candida albicans Andr\u00e9 Luis Souza dos Santos","volume":"1","author":"Dos Santos AL","year":"2010","journal-title":"World J Biol Chem"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.femsim.2003.12.006","article-title":"Anti-retroviral therapy with protease inhibitors decreases virulence enzyme expression in vivo by Candida albicans without selection of avirulent fungus strains or decreasing their anti-mycotic susceptibility","volume":"41","author":"De Bernardis F","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"5-6","key":"ref32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11046-014-9753-5","article-title":"Yeast Oropharyngeal colonization in human Immunodeficiency virus-infected patients in central Taiwan","volume":"177","author":"Ho MW","year":"2014","journal-title":"Mycopathologia"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1469-0691.2009.02707.x","article-title":"Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization","volume":"15","author":"Delgado AC","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.oooo.2015.03.008","article-title":"Oral carriage of Candida species in HIV-infected patients during highly active antiretroviral therapy (HAART) in Bel\u00e9m, Brazil","volume":"120","author":"Ribeiro Ribeiro AL","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.28666","article-title":"In Vitro Susceptibility and Trailing Growth Effect of Clinical Isolates of Candida Species to Azole Drugs","volume":"9","author":"Zomorodian K","year":"2016","journal-title":"Jundishapur J Microbiol"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.5021\/ad.2015.27.6.715","article-title":"Antifungal Susceptibility Testing with Etest for Candida Species Isolated from Patients with Oral Candidiasis","volume":"27","author":"Song YB","year":"2015","journal-title":"Ann Dermatol"}],"container-title":["Einstein (S\u00e3o Paulo)"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/eins\/v16n3\/1679-4508-eins-16-03-eAO4224.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T15:23:41Z","timestamp":1534346621000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1679-45082018000300203&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018]]}},"alternative-id":["S1679-45082018000300203"],"URL":"https:\/\/doi.org\/10.1590\/s1679-45082018ao4224","relation":{},"ISSN":["2317-6385","1679-4508"],"issn-type":[{"value":"2317-6385","type":"electronic"},{"value":"1679-4508","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,6]]}}}